Healthy People Initiative (HPI)
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Apr 23, 2018
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial, titled "A Healthy People Initiative," is focused on helping low-income individuals who are at risk for HIV and Hepatitis-C, particularly those who also struggle with nicotine dependence and substance use disorders. The goal is to improve their overall quality of life by providing support through life skills training, access to health services, and opportunities for education and short-term work or volunteering. By connecting participants with local businesses and resources, the study aims to create a supportive community that helps them reduce smoking and improve their health and well-being.
To participate in this trial, individuals must be at least 16 years old, living in Ottawa or Toronto, and currently smoking ten or more cigarettes a day for the past year. They should also have used multiple substances in the past year. Participants can expect to engage in various programs that promote personal growth, social connections, and health education, all while working towards reducing the impact of smoking and improving their overall health. It's important to note that individuals currently receiving treatment for addictions or enrolled in other smoking cessation programs are not eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be 16 years or older, reside in Ottawa or Toronto,
- • Have smoked tobacco in the past 7 days
- • Identify as low socioeconomic status and/or at risk of homelessness, and be available for in-person follow-up for one year.
- Exclusion criteria:
- • Declining consent
- • Any person who is in or planning on accessing addictions treatment (in-patient drug rehabilitation) in Ottawa or Toronto and hence will be unavailable for follow up
- • Currently or recently (in the past 30 days) enrolled in any other smoking cessation program
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Smita Pakhalé, MD, MSc
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials